At RCW, we recognise the vital role that unlicensed medicines, or “specials,” play in patient care. These products are essential for addressing specific patient needs, often involving unique formulations, dosages, or delivery methods tailored to individual conditions. Our commitment to providing these medicines ensures that healthcare professionals can offer effective treatment options for their patients, even in complex scenarios.
Pharmaceutical Services, Specials
Regulatory Compliance and Standards
Our process for supplying specials adheres to stringent regulatory standards, ensuring compliance with the guidelines set forth by authorities such as the MHRA. This includes sourcing these unlicensed medicines from reputable manufacturers, maintaining high-quality standards, and ensuring appropriate documentation. We work closely with healthcare providers to assess their specific requirements, facilitating the efficient procurement and distribution of these products.
Expertise in Regulatory Landscape
Our dedicated team is well-versed in the regulatory landscape surrounding unlicensed medicines. We ensure that all specials are supplied with the necessary information, including indications, contraindications, and safety profiles. By prioritising patient safety and efficacy, RCW is committed to supporting healthcare providers in delivering exceptional care. Our focus on unlicensed medicines reflects our broader mission to address the diverse and evolving needs of the healthcare sector.
Ensuring Swift Access
Through our robust supply chain and partnerships with trusted manufacturers, we aim to make these essential products readily available to healthcare facilities, enabling timely access to the treatments patients need most.

